在土耳其治疗 Behçet Uveitis
Pınar Çakar Özdal1, Fatime Nilüfer Yalçındağ2, Yasemin Özdamar Erol3
1University of Health Sciences Türkiye, Ulucanlar Eye Training and Research Hospital, Clinic of Ophthalmology, Ankara, Türkiye.
Turkish journal of ophthalmology
|August 29, 2024
概括
土耳其膜炎专家在很大程度上遵循贝希特膜炎 (BU) 治疗的指南. 然而,关于怀孕,疫苗接种和对这种致盲眼病的手术规划存在知识缺口.
科学领域:
- 眼科医生 眼科 眼科
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 贝赫特视膜炎 (BU) 是一种严重的眼部炎症状况,具有显著的视觉发病率.
- 有效的管理依赖于及时治疗,以抑制炎症和预防视力丧失.
研究的目的:
- 评估目前的治疗策略和管理实践,土耳其紫外线炎专家的贝赫特紫外线炎.
- 确定需要改进信息共享和意识的领域,特别是关于特殊患者群体和程序.
主要方法:
- 一个基于网络的调查分发给土耳其各地的耳炎专家.
- 该调查包括16个问题,涵盖治疗启动,药物选择,监测和管理特定情况,如怀孕,疫苗接种和手术.
- 分析了49名眼科医生的回答,以了解当前的做法.
主要成果:
- 专家通常会遵守已确定的指导方针,开始治疗,选择疗法,并监测BU的安全性.
- 关于怀孕期间BU的管理和疫苗接种协议的知识和共识存在重大差距.
- 在BU患者的白内障手术所需的预防措施方面缺乏共识.
结论:
- 虽然遵循BU的核心治疗原则,但显然需要加强和传播有关管理眼科手术准备,安全监测和怀孕和疫苗接种期间特定患者护理的信息.
- 进一步的研究和指导方针的制定是有必要的,以解决目前的知识缺陷在贝塞特膜炎的管理.
相关概念视频
Open Angle Glaucoma: Treatment
408
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
408
Angle Closure Glaucoma: Treatment
454
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
454
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
Inflammatory Bowel Disease IV: Pharmacological Management
122
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
122
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174


